Comparison of the Impact of Conventional Hemodialysis and Hemodiafiltration Techniques on the Evolution of Certain Mineral Bone Parameters in Chronic Hemodialysis Patients
DOI:
https://doi.org/10.3889/oamjms.2022.10276Keywords:
Mineral bone parameters, Chronic hemodialysis, Conventional hemodialysis, HemodiafiltrationAbstract
Objective: The aim of this study was to compare the impact of conventional hemodialysis (HDC) and hemodiafiltration (HDF) techniques on the evolution of the parameters of phosphocalcic metabolism in chronic hemodialysis patients.
Methods: This is a retrospective, descriptive and analytical study carried out in the hemodialysis center of Agadir medico-surgical center during 2015. The total number of patients is 34, 18 were treated by HDC ie 52.9% of cases. Also, 16 patients underwent HDF, ie 47.1% of cases. With each of the 2 techniques, the following parameters were measured: To assess the PTH level, we performed 3 measurements. To evaluate calcium, phosphorus, albumine and CRP levels, 7 measurements were taken. The data were entered via Excel and analyzed through Jamovi 1.6.9 software. We used the Wilcoxon or the Mann-Whitney test for the means. The factors associated with the variation of the studied parameters were analyzed in univariate and multivariate analyzes using the binary logistic regression model.
Results: Our population was made up of 41.2% women and 58.8% men. Their average age was 55 ± 11 years. Also, 82.3% of cases had a normal build, 11.7% were overweight and 6% were moderately obese. The distribution of patients according to the causal nephropathy of chronic renal insufficiency presented a predominance of diabetic nephropathy (32.3%) followed by vascular pathology in 10 patients (29.4%). There was no statistically significant difference in the evolution of the levels of the parameters studied (PTH, calcium, phosphorus, albumin and CRP levels) over time. Univariate analysis showed that only the initial nephropathy factors: other nephropathy-vascular nephropathy (p= 0.028; OR=0.060; IC95% [0.004-0.734]) and diabetic nephropathy-vascular nephropathy (p= 0.011; OR=0.050; IC95% [0.004-0.508]) were associated with the variation of the studied parameters. The same factors also emerge in the multivariate analysis: other nephropathy-vascular nephropathy (p= 0.034; OR=0.044; IC95% [0.002-0.791]) and diabetic nephropathy-vascular nephropathy (p= 0.009; OR=0.032; IC95% [0.002-0.429]).
Conclusion: According to our results, it seems that there are no significant differences in the evolution of some mineral bone parameters studied with the HDC and HDF techniques.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Su W, Cao R, Zhang XY, Guan Y. Aquaporins in the kidney: Physiology and pathophysiology. Am J Physiol Renal Physiol. 2020;318(1):F193-203. https://doi.org/10.1152/ajprenal.00304.2019 PMid:31682170 DOI: https://doi.org/10.1152/ajprenal.00304.2019
Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480-90. https://doi.org/10.1152/advan.00121.2016 PMid:27756725 DOI: https://doi.org/10.1152/advan.00121.2016
Dhondup T, Qian Q. Electrolyte and acid-base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif. 2017;43(1-3):179-88. https://doi.org/10.1159/000452725 PMid:28114143 DOI: https://doi.org/10.1159/000452725
Trajceska L, Mladenovska D, Dzekova-Vidimliski P, Sikole A. Quality of life-repeated measurements are needed in dialysis patients. Open Access Maced J Med Sci. 2018;6(8):1410-2. https://doi.org/10.3889/oamjms.2018.305 PMid:30159066 DOI: https://doi.org/10.3889/oamjms.2018.305
Jabbar A, Qureshi R, Dhrolia M, Nasir K, Ahmad A. Variety of cardiac events in hospitalized chronic kidney disease patients. Cureus. 2021;13(10):e18801. https://doi.org/10.7759/cureus.18801 PMid:34804663 DOI: https://doi.org/10.7759/cureus.18801
Jha CM. Cost-effectiveness of home hemodialysis with bedside portable dialysis machine “DIMI” in the United Arab Emirates. Cureus. 2021;13(10):e18549. https://doi.org/10.7759/cureus.18549 PMid:34754693 DOI: https://doi.org/10.7759/cureus.18549
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322(13):1294-304. https://doi.org/10.1001/jama.2019.14745 PMid:31573641 DOI: https://doi.org/10.1001/jama.2019.14745
Reynolds BS, Lefebvre HP. Feline CKD: Pathophysiology and risk factors--what do we know? J Feline Med Surg. 2013;15(Suppl 1):3-14. https://doi.org/10.1177/1098612X13495234 PMid:23999182 DOI: https://doi.org/10.1177/1098612X13495234
Asserraji M, Maoujoud O, Belarbi M, Oualim Z. Epidemiological profile of end stage renal disease at the Military Hospital in Rabat, Morocco. Pan Afr Med J. 2015;20:439. https://doi.org/10.11604/pamj.2015.20.439.3352 PMid:26309471 DOI: https://doi.org/10.11604/pamj.2015.20.439.3352
Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol. 2003;14(12):3270-7. https://doi.org/10.1097/01.asn.0000100127.54107.57 PMid:14638926 DOI: https://doi.org/10.1097/01.ASN.0000100127.54107.57
Canaud B, Leray-Moragués H. Conduite de l’hémodialyse et prévention de ses complications. EMC-Néphrologie. 2006; 1(1):1-21. https://doi.org/10.1016/s1762-0945(06)43988-7 DOI: https://doi.org/10.1016/S1762-0945(06)43988-7
Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18(7):1272-80. https://doi.org/10.1093/ndt/gfg074 PMid:12808161 DOI: https://doi.org/10.1093/ndt/gfg074
Roumeliotis S, Mallamaci F, Zoccali C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: A 2020 update. J Clin Med. 2020;9(8):2359. https://doi.org/10.3390/jcm9082359 PMid:32718053 DOI: https://doi.org/10.3390/jcm9082359
Canaud B, Vienken J, Ash S, Ward RA, Kidney Health Initiative HDF Workgroup. Hemodiafiltration to address unmet medical needs ESKD patients. Clin J Am Soc Nephrol. 2018;13(9):1435-43. https://doi.org/10.2215/CJN.12631117 PMid:29511057 DOI: https://doi.org/10.2215/CJN.12631117
Maduell F. Hemodiafiltration versus conventional hemodialysis: Should “conventional” be redefined? Semin Dial. 2018;31(6):625-32. https://doi.org/10.1111/sdi.12715 PMid:29813181 DOI: https://doi.org/10.1111/sdi.12715
Almueilo SH. In: Karkar A, editor. Quality of Life on Online Hemodiafiltration (HDF). Ch. 08. Rijeka: IntechOpen; 2016. https://doi.org/10.5772/64591 DOI: https://doi.org/10.5772/64591
Su SF, Ng HY, Huang TL, Chi PJ, Lee YT, Lai CR, et al. Survey of depression by Beck Depression Inventory in uremic patients undergoing hemodialysis and hemodiafiltration. Ther Apher Dial. 2012;16(6):573-9. https://doi.org/10.1111/j.1744-9987.2012.01094.x PMid:23190518 DOI: https://doi.org/10.1111/j.1744-9987.2012.01094.x
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487-97. https://doi.org/10.1681/ASN.2012080875 PMid:23411788 DOI: https://doi.org/10.1681/ASN.2012080875
Schiffl H, Lang SM, Fischer R. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy. Int Urol Nephrol. 2013;45(5):1389-96. https://doi.org/10.1007/s11255-012-0336-4 PMid:23225079 DOI: https://doi.org/10.1007/s11255-012-0336-4
Mora-Bravo FG, De-La-Cruz G, Rivera S, Ramírez AM, Raimann JG, Pérez-Grovas H. Association of intradialytic hypotension and convective volume in hemodiafiltration: Results from a retrospective cohort study. BMC Nephrol. 2012;13:106. https://doi.org/10.1186/1471-2369-13-106 PMid:22963170 DOI: https://doi.org/10.1186/1471-2369-13-106
Oates T, Pinney JH, Davenport A. Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin response. Am J Nephrol. 2011;33(1):70-5. https://doi.org/10.1159/000322834 PMid:21178336 DOI: https://doi.org/10.1159/000322834
van der Weerd NC, Den Hoedt CH, Blankestijn PJ, Bots ML, van den Dorpel MA, Lévesque R, et al. Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: Results from a randomized controlled trial (CONTRAST). PLoS One. 2014;9(4):e94434. https://doi.org/10.1371/journal.pone.0094434 PMid:24743493 DOI: https://doi.org/10.1371/journal.pone.0094434
Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol. 2000;11(12):2344-50. https://doi.org/10.1681/ASN.V11122344 PMid:11095657 DOI: https://doi.org/10.1681/ASN.V11122344
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Lamia Slimani, Fayssal Jhilal, Samir Ahid, Amr Maoujoud (Author)
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0